Related Experiment Video
Updated: Aug 23, 2025

08:56
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
Published on: October 7, 2021
2.8K
Upper Extremity Examination for Neuromuscular Diseases (U-EXTEND): Protocol for a Multimodal Feasibility Study
Robert Gutierrez1, Allison McCrady2, Chelsea Masterson3
1School of Engineering & Applied Science, University of Virginia, Charlottesville, VA, United States.
JMIR Research Protocols
|October 27, 2022
Summary
This study introduces a novel multimodal approach using ultrasound and wearable sensors to precisely measure motor function changes in children with neuromuscular diseases like spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD). This method aims to accelerate the development of new treatments by capturing subtle functional improvements.
Area of Science:
- Neurology
- Biomedical Engineering
- Rehabilitation Medicine
Background:
- Neuromuscular diseases (e.g., spinal muscular atrophy, Duchenne muscular dystrophy) cause significant motor impairment and can be fatal.
- Current motor scale tests may not capture subtle functional changes, necessitating new evaluation methods.
- Novel treatments are emerging, increasing the need for sensitive outcome measures in clinical trials.
Purpose of the Study:
- To develop and validate a novel, multimodal paradigm for assessing upper extremity motor function in pediatric neuromuscular diseases.
- To create objective, quantitative measures of muscle structure and function beyond current clinical metrics.
- To accelerate the development pipeline for new childhood neuromuscular disease treatments through improved clinical trial endpoints.
Main Methods:
- The Upper Extremity Examination for Neuromuscular Diseases (U-EXTEND) study employs ultrasound imaging and handheld dynamometry to assess muscle size, quality, and function (biceps, pronator).
- Wearable wireless sensor technology captures motion data during activities of daily living.
- Data from participants with SMA and DMD will be compared to a healthy cohort to establish normative values and calculate a motor function score.
Main Results:
- Participant enrollment began in January 2021, with 44 individuals (9 SMA, 20 DMD, 15 healthy) enrolled by July 2022.
- Data collection is ongoing for both ultrasound and sensor-based measurements.
- Initial results were anticipated for publication in summer 2022.
Conclusions:
- The study hypothesizes that the multimodal approach will precisely quantify motor function changes in neuromuscular disease patients.
- This system aims to track the minimal clinically important difference, enabling better assessment of novel treatment efficacy.
- Comparing muscle and functional scores over time will detect subtle improvements in patient function and intrinsic muscle properties.
Keywords:
cross-sectional areaechogenicityinertial measurement unitmHealthmotor functionneuromuscular disordersspecific torqueubiquitous computing
